Cargando…

HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report

BACKGROUND: Visceral leishmaniasis is caused by a protozoan parasite, Leishmania donovani and transmitted by the bite of female sandflies. India is endemic for this disease. On the other hand, India contributes to the largest number of cases of HIV as well. CASE PRESENTATION: We hereby report an unu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Krishna, Sinha, Prabhat Kumar, Rabidas, Vidya, Kumar, Nawin, Bimal, Sanjiva, Verma, Neena, Lal, Chandrasekhar, Das, Pradeep
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2561008/ https://www.ncbi.nlm.nih.gov/pubmed/18817545 http://dx.doi.org/10.1186/1757-1626-1-183

Ejemplares similares

Tuberous sclerosis with visceral leishmaniasis: a case report
por: Pandey, Krishna, et al.
Publicado: (2009)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Microalbuminuria and Glomerular Filtration Rate in Paediatric Visceral Leishmaniasis
por: Verma, Neena, et al.
Publicado: (2013)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
por: Das, Vidya Nand Rabi, et al.
Publicado: (2020)

Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study
por: Verma, Neena, et al.
Publicado: (2015)

Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study
por: Das, Sushmita, et al.
Publicado: (2016)

Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients
por: SINGH, Ashish Kumar, et al.
Publicado: (2018)

Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients
por: Vijayamahantesh,, et al.
Publicado: (2016)

Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis
por: Jamal, Fauzia, et al.
Publicado: (2017)

Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
por: Sundar, Shyam, et al.
Publicado: (2014)

Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2014)

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
por: Burza, Sakib, et al.
Publicado: (2014)

Advanced case of PKDL due to delayed treatment: A rare case report
por: Topno, Roshan Kamal, et al.
Publicado: (2020)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2009)

Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis
por: Dikhit, Manas Ranjan, et al.
Publicado: (2017)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2020)

Validating Immunomodulatory Responses of r-LdODC Protein and Its Derived HLA-DRB1 Restricted Epitopes against Visceral Leishmaniasis in BALB/c Mice
por: Pandey, Rajkishor, et al.
Publicado: (2022)

Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India
por: Garapati, Pavan, et al.
Publicado: (2018)

To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)
por: Rabi Das, Vidya Nand, et al.
Publicado: (2017)

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Diagnosis of Visceral Leishmaniasis in Bihar India: Comparison of the rK39 Rapid Diagnostic Test on Whole Blood Versus Serum
por: Matlashewski, Greg, et al.
Publicado: (2013)

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2016)

Immunomodulation in Human Dendritic Cells Leads to Induction of Interferon-Gamma Production by Leishmania donovani Derived KMP-11 Antigen via Activation of NF-κB in Indian Kala-Azar Patients
por: Chaudhary, Rajesh, et al.
Publicado: (2014)

Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis
por: Veeri, Rajendra Babu, et al.
Publicado: (2019)

AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial( )
por: Burza, Sakib, et al.
Publicado: (2022)

Modulation of the immune response and infection pattern to Leishmania donovani in visceral leishmaniasis due to arsenic exposure: An in vitro study
por: Ahmed, Ghufran, et al.
Publicado: (2019)

Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort study
por: Owen, Sophie I, et al.
Publicado: (2021)

Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient
por: Bastola, Anup, et al.
Publicado: (2019)

Immunoproteomic Identification and Characterization of Leishmania Membrane Proteins as Non-Invasive Diagnostic Candidates for Clinical Visceral Leishmaniasis
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2018)

RETRACTED ARTICLE: Nucleic acid sensing activates the innate cytosolic surveillance pathway and promotes parasite survival in visceral leishmaniasis
por: Das, Sushmita, et al.
Publicado: (2019)

Retraction Note: Nucleic acid sensing activates the innate cytosolic surveillance pathway and promotes parasite survival in visceral leishmaniasis
por: Das, Sushmita, et al.
Publicado: (2022)

Revealing a Novel Antigen Repressor of Differentiation Kinase 2 for Diagnosis of Human Visceral Leishmaniasis in India
por: Bhattacharyya, Anirban, et al.
Publicado: (2022)

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India
por: Mahajan, Raman, et al.
Publicado: (2015)

Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
por: Pandey, Krishna, et al.
Publicado: (2020)

Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison
por: Siddiqui, Niyamat A., et al.
Publicado: (2016)

Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2016)

One More Death from Visceral Leishmaniasis Has Gone by Unnoticed. What Can Be Done?
por: Matlashewski, Greg, et al.
Publicado: (2013)

Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India
por: Sinha, Prabhat K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1cthecuv59ricbmmhu4ub5dlqj